These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2563558)

  • 1. Anaphylactic reactions to teniposide.
    Siddall SJ; Martin J; Nunn AJ
    Lancet; 1989 Feb; 1(8634):394. PubMed ID: 2563558
    [No Abstract]   [Full Text] [Related]  

  • 2. Teniposide-induced hypersensitivity reactions in children.
    Carstensen H; Nolte H; Hertz H
    Lancet; 1989 Jul; 2(8653):55. PubMed ID: 2567836
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
    Gutierrez ML; Crooke ST
    Cancer Treat Rev; 1979 Sep; 6(3):153-64. PubMed ID: 394834
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.
    Montaldo PG; Figoli F; Zanette ML; Sorio R; Zucchetti M; Tirelli U; D'Incalci M
    Oncology; 1990; 47(1):55-61. PubMed ID: 2300386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypersensitivity to VM-26].
    Köster B; Ritter J; Bode U
    Klin Padiatr; 1984; 196(3):178-80. PubMed ID: 6540829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to teniposide in children.
    Carstensen H; Nolte H; Hertz H; Jensen T
    J Clin Oncol; 1987 Sep; 5(9):1491-2. PubMed ID: 3625264
    [No Abstract]   [Full Text] [Related]  

  • 7. Podophyllotoxin derivatives VP-16 and VM-26.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1988; 10():57-63. PubMed ID: 3079398
    [No Abstract]   [Full Text] [Related]  

  • 8. Podophyllotoxin derivatives VP-16 and VM-26.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1987; 9():67-70. PubMed ID: 3079416
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
    Hayes FA; Abromowitch M; Green AA
    Cancer Treat Rep; 1985 Apr; 69(4):439-41. PubMed ID: 3857970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of teniposide in advanced breast cancer.
    Boas J; Rasmussen D; Hansen OP; Engelholm SA; Dombernowsky P
    Cancer Chemother Pharmacol; 1990; 25(6):463-4. PubMed ID: 2311176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teniposide is not effective in chronic lymphocytic leukemia.
    Zagonel V; Tirelli U; Veronesi A; Galligioni E; Tumolo S; Roncadin M; Carbone A; Grigoletto E
    Blut; 1986 Jan; 52(1):59-61. PubMed ID: 3632912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precipitation of teniposide during infusion.
    Am J Hosp Pharm; 1990 Mar; 47(3):512, 518. PubMed ID: 2316530
    [No Abstract]   [Full Text] [Related]  

  • 13. VM 26 and VP 16-213: a comparative analysis.
    Rozencweig M; Von Hoff DD; Henney JE; Muggia FM
    Cancer; 1977 Jul; 40(1):334-42. PubMed ID: 328129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors of children.
    Seiler RW
    Helv Paediatr Acta; 1980 Mar; 35(1):51-6. PubMed ID: 7410103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma.
    Rivera G; Green A; Hayes A; Avery T; Pratt C
    Cancer Treat Rep; 1977 Oct; 61(7):1243-8. PubMed ID: 589594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
    Kondrat'eva NA; Makhonova LA; Maiakova SA; Vialushkin BIa
    Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):12-6. PubMed ID: 7015318
    [No Abstract]   [Full Text] [Related]  

  • 17. The podophyllotoxin derivatives VP16-213 and VM26.
    Issell BF
    Cancer Chemother Pharmacol; 1982; 7(2-3):73-80. PubMed ID: 7044593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
    Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
    Pritchard J; Whelan R; Hill BT
    Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
    Radice PA; Bunn PA; Ihde DC
    Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.